BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29071849)

  • 1. [Efficacy and safety of Lianhua Qingwen capsule for influenza: a systematic review].
    Niu QQ; Chen Y; Liu Y; Mao SZ; Wang H; Zheng WK; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1474-1481. PubMed ID: 29071849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic review of efficacy and safety of Lianhua Qingwen Capsules in treatment of viral influenza].
    Wang SH; Liu JF; Zhang YL; Dong Z
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1503-1508. PubMed ID: 31090311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
    Li WF; Hu CC; Ding YL; Yuan B
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic review and Meta-analysis of Lianhua Qingwen preparations combined with Oseltamivir in treatment of influenza].
    Yan YM; Yang XJ; Zhao CX; Li ZY; Zhao GZ; Guo YH; Li B; Liu QQ
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4238-4247. PubMed ID: 36046914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019.
    Wang DC; Yu M; Xie WX; Huang LY; Wei J; Lei YH
    J Integr Med; 2022 Jan; 20(1):26-33. PubMed ID: 34782291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
    Zeng M; Li L; Wu Z
    PLoS One; 2020; 15(9):e0238828. PubMed ID: 32915877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
    Zhang X; Cao D; Liu J; Zhang Q; Liu M
    Medicine (Baltimore); 2020 Jul; 99(30):e21404. PubMed ID: 32791754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis and systematic review of efficacy and safety of Lianhua Qingwen in adjuvant treatment of adult pneumonia].
    Lu ZJ; Wu LY; Mou YY; Duan HM; Chen RC; Xiao Y; Zheng WJ
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):1000-1009. PubMed ID: 33645106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.
    Yang C; Wang Y; He J; Yan W; Jiang H; Chen Q; Li L; Yang Z
    Evid Based Complement Alternat Med; 2020; 2020():3196375. PubMed ID: 32565852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Lianhuaqingwen capsule compared with oseltamivir for influenza A virus infection: a meta-analysis of randomized, controlled trials.
    Zhao P; Yang HZ; Lv HY; Wei ZM
    Altern Ther Health Med; 2014; 20(2):25-30. PubMed ID: 24657957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19).
    Zhuang J; Dai X; Wu Q; Cai H; Fu X; Zhang W; Chen B
    Complement Ther Med; 2021 Aug; 60():102754. PubMed ID: 34153446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs.
    Chen Y; Zhang C; Wang N; Feng Y
    Chin J Nat Med; 2023 May; 21(5):383-400. PubMed ID: 37245876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
    Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
    Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic review and Meta-analysis of efficacy and safety of Shufeng Jiedu Capsules in treatment of influenza].
    Zhou F; Zhao GZ; Li B; Xu XL; Shi YF; Mao YY; Tian JH; Liu QQ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6216-6224. PubMed ID: 38114228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Lianhua Qingwen as an adjuvant treatment for influenza in Chinese patients: A meta-analysis.
    Yuan C; Guan Y
    Medicine (Baltimore); 2024 Jan; 103(3):e36986. PubMed ID: 38241551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.
    Ma C; Chen B; Li Y; Gu L; Dong J; Xu Z; Wei L; He Z; Nie X; Feng S; Cao B; Sun L; Yang L; Li X; Jiang R
    Front Med (Lausanne); 2023; 10():1302219. PubMed ID: 38314028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism and material basis of
    Yan H; Zou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):20-30. PubMed ID: 33509749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19: A systematic review and network meta-analysis.
    Wu X; Li W; Qin Z; Xue L; Huang G; Luo Z; Chen Y
    Medicine (Baltimore); 2021 Oct; 100(40):e27372. PubMed ID: 34622839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal medicine Kuntai capsule for treatment of menopausal syndrome: a systematic review of randomized clinical trials.
    Zhou Q; Tao J; Song H; Chen A; Yang H; Zuo M; Li H
    Complement Ther Med; 2016 Dec; 29():63-71. PubMed ID: 27912959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanreqing Injection () for Patients with Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Qu CC; Zhao GZ; Wang XP; Xu XL; Li B; Guo YH; Liu QQ
    Chin J Integr Med; 2020 Dec; 26(12):936-942. PubMed ID: 32572781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.